Evidence map›Paper›PMID 31093313›Full record

ArticleOxidative medicine and cellular longevity2019

Alpha Lipoic Acid Improves Endothelial Function and Oxidative Stress in Mice Exposed to Chronic Intermittent Hypoxia.

Mohammad Badran, Bisher Abuyassin, Saeid Golbidi, Najib Ayas, Ismail Laher

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Nocturia and obstructive sleep apnoea.Nature reviews. Urology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohammad BadranDepartment of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, Canada.ORCID 0000-0001-7073-741X
Bisher AbuyassinDepartment of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, Canada.ORCID 0000-0003-3923-6646
Saeid GolbidiDepartment of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, Canada.ORCID 0000-0001-9166-2023
Najib AyasDivisions of Critical Care and Respiratory Medicine, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Ismail LaherDepartment of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, Canada.ORCID 0000-0002-3917-4417
University of British Columbia · CAUniversity of British Columbia Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveObstructive sleep apnea (OSA) is characterized by recurrent airway collapse that causes chronic intermittent hypoxia (CIH). OSA is associated with systemic inflammation and oxidative stress resulting in endothelial dysfunction and cardiovascular disease (CVD). Alpha lipoic acid (ALA) is a potent antioxidant with anti-inflammatory properties. We hypothesized that dietary ALA can improve endothelial function of mice exposed to CIH.

methodsMice were exposed to either CIH or intermittent air (IA) and treated with dietary ALA (0.2%

resultsMice exposed to CIH exhibited endothelial dysfunction accompanied by systemic oxidative stress and inflammation as well as increased aortic expression of inflammatory cytokines. Furthermore, CIH led to eNOS uncoupling. Treatment with dietary ALA reversed endothelial dysfunction in mice exposed to CIH, lowered systemic oxidative stress and inflammation, prevented the increases of inflammatory cytokine gene expression, increased the expression of antioxidant enzymes, and preserved eNOS in a coupled state.

conclusionALA attenuates endothelial dysfunction by preventing oxidative stress and inflammation and restoring nitric oxide bioavailability in mice exposed to CIH. Our data suggests the potential beneficial use of ALA as adjunctive therapy in OSA.

Indexed as

Aldehyde DehydrogenaseAldehydesAnimalsArginineBiomarkersChronic DiseaseCytokinesEndothelium, VascularHypoxiaInflammationMaleMice, Inbred C57BLModels, BiologicalNitric OxideNitric Oxide Synthase Type IIIOxidative Stress4-hydroxy-2-nonenalAldehyde DehydrogenaseAldehydesArginineBiomarkersCytokinesdimethylarginineNitric OxideNitric Oxide Synthase Type IIIThioctic Acid

Identifiers

PMID31093313
PMCPMC6481039
OpenAlexW2937700756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.